Maryalice Stetler-Stevenson Selected Research

Hairy Cell Leukemia

12/2021	Long term follow-up of a phase II study of cladribine with concurrent rituximab with hairy cell leukemia variant.
10/2020	Randomized Phase II Study of First-Line Cladribine With Concurrent or Delayed Rituximab in Patients With Hairy Cell Leukemia.
1/2020	Expression of the muscle-associated gene MYF6 in hairy cell leukemia.
1/2018	Minimal residual hairy cell leukemia eradication with moxetumomab pasudotox: phase 1 results and long-term follow-up.
12/2013	Cladribine with immediate rituximab for the treatment of patients with variant hairy cell leukemia.
11/2013	Bendamustine and rituximab in relapsed and refractory hairy cell leukemia.
5/2012	Phase I trial of anti-CD22 recombinant immunotoxin moxetumomab pasudotox (CAT-8015 or HA22) in patients with hairy cell leukemia.
6/2011	Response of hairy cell leukemia to bendamustine.
6/2011	Recombinant immunotoxins and other therapies for relapsed/refractory hairy cell leukemia.
11/2009	VH4-34+ hairy cell leukemia, a new variant with poor prognosis despite standard therapy.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Maryalice Stetler-Stevenson Research Topics

Disease

28	Neoplasms (Cancer) 11/2020 - 12/2003
16	Hairy Cell Leukemia 12/2021 - 05/2006
15	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2022 - 03/2010
15	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2021 - 06/2003
11	Multiple Myeloma 11/2021 - 02/2005
10	Residual Neoplasm 01/2022 - 05/2006
9	Lymphoma (Lymphomas) 09/2019 - 02/2005
6	Smoldering Multiple Myeloma 11/2021 - 06/2014
5	Leukemia 01/2022 - 01/2016
5	Disease Progression 01/2018 - 09/2005
5	Hemolytic-Uremic Syndrome 10/2017 - 09/2005
5	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 01/2017 - 04/2009
4	Lymphocytosis 01/2021 - 09/2002
3	Hematologic Neoplasms (Hematological Malignancy) 10/2018 - 03/2010
3	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2018 - 07/2014
3	Hypoalbuminemia 10/2017 - 09/2005
3	B-Cell Lymphoma (Lymphoma, B Cell) 02/2015 - 02/2005
2	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 12/2021 - 10/2020
2	Circulating Neoplastic Cells 04/2016 - 12/2011
2	Infections 11/2015 - 06/2009
2	Burkitt Lymphoma (Burkitt's Lymphoma) 07/2014 - 02/2005
2	Edema (Dropsy) 05/2012 - 09/2005
2	Fatigue 05/2012 - 09/2005
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2011 - 09/2005
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 03/2010 - 01/2008
2	T-Cell Lymphoma (Lymphoma, T Cell) 11/2009 - 04/2009
2	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 11/2009 - 04/2009
2	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 04/2009 - 03/2009
1	Cytokine Release Syndrome 12/2021
1	Hypertriglyceridemia 12/2021
1	Hyperferritinemia 12/2021
1	Neutropenia 12/2021
1	Hyperbilirubinemia 12/2021
1	Multi-centric Castleman's Disease 01/2021
1	Kaposi Sarcoma (Kaposi's Sarcoma) 01/2021
1	Primary Effusion Lymphoma 01/2021
1	Hemorrhage 10/2020
1	Thrombocytopenia (Thrombopenia) 10/2020
1	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 01/2019
1	Cardiotoxicity 11/2018
1	Mesothelioma 01/2018
1	Monoclonal Gammopathy of Undetermined Significance 01/2018
1	Aspergillosis 12/2017
1	Capillary Leak Syndrome 10/2017
1	Thrombotic Microangiopathies 10/2017
1	Weight Gain 10/2017

Drug/Important Bio-Agent (IBA)

18	Chimeric Antigen ReceptorsIBA 12/2022 - 11/2010
9	AntigensIBA 01/2022 - 09/2005
9	Immunotoxins (Immunotoxin)IBA 10/2018 - 09/2005
8	ibrutinibIBA 11/2020 - 02/2015
7	Rituximab (Mabthera)FDA Link 12/2021 - 09/2002
6	Cladribine FDA LinkGeneric 12/2021 - 05/2006
6	Lenalidomide (CC 5013)FDA Link 11/2021 - 09/2015
6	Dexamethasone (Maxidex)FDA LinkGeneric 11/2021 - 09/2015
5	carfilzomibIBA 11/2021 - 09/2015
4	purineIBA 12/2021 - 12/2013
4	immunotoxin HA22IBA 01/2018 - 06/2011
3	Agammaglobulinaemia Tyrosine KinaseIBA 01/2020 - 04/2016
3	B-Cell Maturation AntigenIBA 01/2018 - 01/2016
3	Transaminases (Aminotransferases)IBA 10/2017 - 09/2005
3	Alemtuzumab (Campath)FDA Link 01/2017 - 04/2009
3	Proteins (Proteins, Gene)FDA Link 02/2012 - 12/2003
3	Tissue Inhibitor of Metalloproteinase-1IBA 09/2008 - 12/2004
2	CD19 AntigensIBA 01/2022 - 11/2010
2	CytokinesIBA 01/2021 - 03/2012
2	fludarabineIBA 11/2020 - 01/2016
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2017
2	Inotuzumab OzogamicinIBA 04/2019 - 01/2019
2	B3(Fv)-PE38KDEL recombinant immunotoxinIBA 01/2016 - 06/2011
2	AntibodiesIBA 01/2016 - 02/2012
2	Monoclonal AntibodiesIBA 01/2016 - 04/2009
2	Immunoglobulin M (IgM)IBA 06/2014 - 01/2011
2	Bendamustine Hydrochloride FDA Link 11/2013 - 06/2011
2	gamma-delta T-Cell Antigen Receptors (T-Cell Receptor delta-Chain)IBA 04/2010 - 09/2005
2	Interleukin-7 (Interleukin 7)IBA 01/2010 - 05/2006
1	blinatumomabIBA 01/2022
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 12/2021
1	avelumabIBA 01/2021
1	serum P-component (CIt)IBA 01/2021
1	ofatumumab FDA Link 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	Interleukin-13IBA 01/2021
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 10/2020
1	Tartrate-Resistant Acid PhosphataseIBA 01/2020
1	AnnexinsIBA 01/2020
1	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2018
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018
1	Surface Antigens (Surface Antigen)IBA 01/2018
1	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 01/2018
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 01/2018
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2018
1	Proteasome InhibitorsIBA 01/2017
1	TrypsinIBA 01/2017

Therapy/Procedure

29	Therapeutics 11/2021 - 09/2005
9	Drug Therapy (Chemotherapy) 10/2017 - 09/2005
4	Immunotherapy 10/2020 - 01/2008
2	Hematopoietic Stem Cell Transplantation 01/2019 - 09/2012
2	Plasmapheresis 06/2009 - 09/2005
1	Radiotherapy 01/2021
1	Platelet Transfusion (Blood Platelet Transfusions) 10/2020